Press "Enter" to skip to content

When Will The Rally In Precipio's Stock End?

Shares of cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) have soared 170% this week after the company said it launched a COVID-19 test on the, Inc. (NASDAQ: AMZN) business platform.

A similar thing happened in July when Precipio first announced its COVID-19 strategy. Shares made an even larger move than they did this week.

Investors should focus on two key levels.

In July, shares reached $8, but by the close, they backed off to $7. Levels that had previously been resistance can become resistance again. If PRPO reaches these levels, there is a good chance the rally stalls out at them once more.


© 2021 Benzinga does not provide investment advice. All rights reserved.

This post was originally published on this site

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *